GCG and type 2 diabetes mellitus: In adults with T2D, clinical ASCVD and HbA1c above the target despite dual therapy, triple therapy with metformin and a combination of two AD1 (SGLT2i and GLP-1 RA) IS RECOMMENDED to improve glycemic control and further reduce cardiovascular events.